Vanda Pharmaceuticals Inc. (VNDA)

Business: Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs.

IPO Date: 12-Apr-2006

Founder, Pres, CEO & Chairman of The Board: Dr. Mihael H. Polymeropoulos M.D.

Sr. VP, CFO & Treasurer: Mr. Kevin Patrick Moran

Listing: NASDAQ: VNDA

Country: United States

Headquarters: Washington, DC

Website: https://www.vandapharma.com

Market cap: $604.44 Mln

Revenue (TTM): $266.21 Mln

Earnings (TTM): $18.07 Mln

Cash: $435.18 Mln

Total Debt: $11.96 Mln

Insider's Holding: 3.56%

Liquidity: Low

52 Week range: $9.24 - 21.86

Shares outstanding: 56,489,700

10 Years Aggregate:

• CFO: $28.22 Mln
• EBITDA: $-9.10 Mln
• Net Profit: $96.08 Mln